GSK stops development of chronic cough drug after late-stage trial miss - Reuters
GSK stops development of chronic cough drug after late-stage trial miss Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxOOTJyXzZma0ZYNnRvRjM1c0kzLWg1eEVWSXdkNVRHTlFZR29CMzFReWlicTZiX0ZUOEdzbTB0UmM4VmlRMTdieHNHT2I5RjJPWHR3X0swbF9Ua0xLTXVfdmVCWDM4aE5mRkJHWTM3d1JOcjFxLWJsQjFVdHQtRHF0dTRud3Z4cXlyR25ZVWhkN2lGTEZrUVJJQ0FCZ0Q4SDU5SE1HcE1NTUdzaUtsQm1aWm5tVFA2SlNKU3hfSWw5R2N0SWlKSDQ0eVBxeTBMTXA3?oc=5" target="_blank">GSK stops development of chronic cough drug after late-stage trial miss</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PMUS FDA flags four deaths in Newron's schizophrenia drug studies - Reuters
US FDA flags four deaths in Newron's schizophrenia drug studies Reuters
October 8, 2026 at 05:47 PMHalozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PMWHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters
October 7, 2026 at 07:39 AMPepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies - Reuters
PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies Reuters
October 7, 2026 at 11:36 AM